Company Description
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products.
The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women’s health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products.
The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions.
Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services.
The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry.
The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes.
It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022.
The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
| Country | United States |
| Founded | 1892 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 51,000 |
| CEO | Peter J. Arduini |
Contact Details
Address: 500 West Monroe Street Chicago, Illinois 60661 United States | |
| Phone | 833-735-1139 |
| Website | gehealthcare.com |
Stock Details
| Ticker Symbol | GEHC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001932393 |
| CUSIP Number | 36266G107 |
| ISIN Number | US36266G1076 |
| Employer ID | 88-2515116 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Thomas J. Westrick | President and Chief Executive Officer of Patient Care Solutions |
| Jan Makela | President and Chief Executive Officer of Imaging |
| Peter J. Arduini | President, Chief Executive Officer and Director |
| James K. Saccaro | Vice President and Chief Financial Officer |
| Dr. Taha Kass-Hout M.D., M.S. | Chief Science and Technology Officer |
| Frank R. Jimenez Esq. | Vice President, General Counsel and Corporate Secretary |
| George Andrew Newcomb | Controller and Chief Accounting Officer |
| Jahid Khandaker | Chief Information Officer |
| Carolynne Borders | Chief Investor Relations Officer |
| Rana Strellis | Chief Corporate Marketing and Communications Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 28, 2024 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| May 30, 2024 | SD | Form - SD |
| May 28, 2024 | 144 | Filing |
| May 23, 2024 | 8-K | Current Report |
| May 17, 2024 | 144 | Filing |
| May 13, 2024 | 144 | Filing |
| Apr 30, 2024 | 10-Q | Quarterly Report |
| Apr 30, 2024 | 8-K | Current Report |
| Apr 15, 2024 | 8-K | Current Report |
| Apr 4, 2024 | ARS | Filing |